Session of 2025
HOUSE BILL No. 2159
By Representatives Proctor and Hoheisel
1-30
1 AN ACT concerning law enforcement; relating to emergency opioid
2 antagonists; creating the emergency opioid antagonists assistance grant
3 fund to assist law enforcement agencies with purchasing emergency
4 opioid antagonists; maintaining immunity for law enforcement agencies
5 and officers for damages resulting from administering an emergency
6 opioid antagonist; removing law enforcement agencies and officers
7 from the state board of pharmacy's statewide opioid antagonist
8 protocol; amending K.S.A. 2024 Supp. 65-16,127 and repealing the
9 existing section.
10
11 Be it enacted by the Legislature of the State of Kansas:
12 New Section 1. (a) There is hereby established in the state treasury
13 the emergency opioid antagonists assistance grant fund, to be administered
14 by the attorney general. All moneys credited to the fund shall be for
15 providing assistance to law enforcement agencies across the state in
16 purchasing emergency opioid antagonists.
17 (2) All expenditures from the emergency opioid antagonists
18 assistance account grant fund shall be made in accordance with
19 appropriation acts upon warrants of the director of accounts and reports
20 issued pursuant to vouchers approved by the attorney general or the
21 attorney general's designee.
22 (c) The attorney general shall develop and implement the emergency
23 opioid antagonists assistance grant program with the goal of providing
24 assistance to law enforcement agencies across the state in purchasing
25 emergency opioid antagonists for law enforcement officers to carry while
26 such officers are on duty. Prioritization of emergency opioid antagonists
27 assistance grant fund moneys shall be given to small law enforcement
28 agencies. Only a law enforcement agency that has adopted a policy
29 requiring the administration of emergency opioid antagonists shall be
30 eligible to receive a grant pursuant to this subsection.
31 (d) On July 1, 2025, and on July 1 of each year thereafter, the director
32 of accounts and reports shall transfer $4,000,000 from the state general
33 fund to the emergency opioid antagonist assistance grant fund.
34 Sec. 2. K.S.A. 2024 Supp. 65-16,127 is hereby amended to read as
35 follows: 65-16,127. (a) As used in this section:
36 (1) "Bystander" means a family member, friend, caregiver or other

HB 2159 2
1 person in a position to assist a person who the family member, friend,
2 caregiver or other person believes, in good faith, to be experiencing an
3 opioid overdose.
4 (2) "Emergency opioid antagonist" means any drug that inhibits the
5 effects of opioids and that is approved by the United States food and drug
6 administration for the treatment of an opioid overdose.
7 (3) (A) "First responder" includes any emergency medical service
8 provider, as defined by K.S.A. 65-6112, and amendments thereto, any law
9 enforcement officer, as defined by K.S.A. 22-2202, and amendments
10 thereto, and any actual member of any organized fire department, whether
11 regular or volunteer.
12 (B) "First responder" does not include any law enforcement officer,
13 as defined in K.S.A. 22-2202, and amendments thereto.
14 (4) (A) "First responder agency" includes, but is not limited to, any
15 law enforcement agency, fire department or criminal forensic laboratory of
16 any city, county or the state of Kansas.
17 (B) "First responder agency" does not include any law enforcement
18 agency.
19 (5) "Opioid antagonist protocol" means the protocol established by
20 the state board of pharmacy pursuant to subsection (b).
21 (6) "Opioid overdose" means an acute condition including, but not
22 limited to, extreme physical illness, decreased level of consciousness,
23 respiratory depression, coma, mania or death, resulting from the
24 consumption or use of an opioid or another substance with which an
25 opioid was combined, or that a layperson would reasonably believe to be
26 resulting from the consumption or use of an opioid or another substance
27 with which an opioid was combined, and for which medical assistance is
28 required.
29 (7) "Patient" means a person believed to be at risk of experiencing an
30 opioid overdose.
31 (8) "School nurse" means a professional nurse licensed by the board
32 of nursing and employed by a school district to perform nursing
33 procedures in a school setting.
34 (9) "Healthcare provider" means a physician licensed to practice
35 medicine and surgery by the state board of healing arts, a licensed dentist,
36 a mid-level practitioner as defined by K.S.A. 65-1626, and amendments
37 thereto, or any person authorized by law to prescribe medication.
38 (b) The state board of pharmacy shall issue a statewide opioid
39 antagonist protocol that establishes requirements for a licensed pharmacist
40 to dispense emergency opioid antagonists to a person pursuant to this
41 section. The opioid antagonist protocol shall include procedures to ensure
42 accurate recordkeeping and education of the person to whom the
43 emergency opioid antagonist is furnished, including, but not limited to:

HB 2159 3
1 Opioid overdose prevention, recognition and response; safe administration
2 of an emergency opioid antagonist; potential side effects or adverse events
3 that may occur as a result of administering an emergency opioid
4 antagonist; a requirement that the administering person immediately
5 contact emergency medical services for a patient; and the availability of
6 drug treatment programs.
7 (c) A pharmacist may furnish an emergency opioid antagonist to a
8 patient or bystander subject to the requirements of this section, the
9 pharmacy act of the state of Kansas and any rules and regulations adopted
10 by the state board of pharmacy thereunder.
11 (d) A pharmacist furnishing an emergency opioid antagonist pursuant
12 to this section may not permit the person to whom the emergency opioid
13 antagonist is furnished to waive any consultation required by this section
14 or any rules and regulations adopted thereunder.
15 (e) Any first responder, scientist or technician operating under a first
16 responder agency or school nurse is authorized to possess, store, distribute
17 and administer emergency opioid antagonists as clinically indicated,
18 provided that all personnel with access to emergency opioid antagonists
19 are trained, at a minimum, on the following:
20 (1) Techniques to recognize signs of an opioid overdose;
21 (2) standards and procedures to store, distribute and administer an
22 emergency opioid antagonist;
23 (3) emergency follow-up procedures, including the requirement to
24 summon emergency ambulance services either immediately before or
25 immediately after administering an emergency opioid antagonist to a
26 patient; and
27 (4) inventory requirements and reporting any administration of an
28 emergency opioid antagonist to a healthcare provider.
29 (f) (1) Any first responder agency electing to provide an emergency
30 opioid antagonist to its employees or volunteers for the purpose of
31 administering the emergency opioid antagonist shall procure the services
32 of a physician to serve as physician medical director for the first responder
33 agency's emergency opioid antagonist program.
34 (2) The first responder agency shall utilize the physician medical
35 director or a licensed pharmacist for the purposes of:
36 (A) Obtaining a supply of emergency opioid antagonists;
37 (B) receiving assistance developing necessary policies and
38 procedures that comply with this section and any rules and regulations
39 adopted thereunder;
40 (C) training personnel; and
41 (D) coordinating agency activities with local emergency ambulance
42 services and medical directors to provide quality assurance activities.
43 (g) (1) Any healthcare provider or pharmacist who, in good faith and

HB 2159 4
1 with reasonable care, prescribes or dispenses an emergency opioid
2 antagonist pursuant to this section shall not, by an act or omission, be
3 subject to civil liability, criminal prosecution or any disciplinary or other
4 adverse action by a professional licensure entity arising from the
5 healthcare provider or pharmacist prescribing or dispensing the emergency
6 opioid antagonist.
7 (2) Any patient, bystander, school nurse, or a first responder, scientist
8 or technician operating under a first responder agency, who, in good faith
9 and with reasonable care, receives and administers an emergency opioid
10 antagonist pursuant to this section to a person experiencing a suspected
11 opioid overdose shall not, by an act or omission, be subject to civil liability
12 or criminal prosecution, unless personal injury results from the gross
13 negligence or willful or wanton misconduct in the administration of the
14 emergency opioid antagonist.
15 (3) Any first responder agency employing or contracting any person
16 that, in good faith and with reasonable care, administers an emergency
17 opioid antagonist pursuant to this section to a person experiencing a
18 suspected opioid overdose shall not, by an act or omission, be subject to
19 civil liability, criminal prosecution, any disciplinary or other adverse
20 action by a professional licensure entity or any professional review.
21 (4) Any law enforcement officer, as defined in K.S.A. 22-2202, and
22 amendments thereto, or law enforcement agency employing or contracting
23 with any person who, in good faith and with reasonable care, administers
24 an emergency opioid antagonist to a person experiencing a suspected
25 opioid overdose shall not, by an act or omission, be subject to civil
26 liability, criminal prosecution, any disciplinary or other adverse action by
27 a professional licensure entity or any professional review.
28 (h) The state board of pharmacy shall adopt rules and regulations as
29 may be necessary to implement the provisions of this section prior to
30 January 1, 2018.
31 (i) This section shall be a part of and supplemental to the pharmacy
32 act of the state of Kansas.
33 Sec. 3. K.S.A. 2024 Supp. 65-16,127 is hereby repealed.
34 Sec. 4. This act shall take effect and be in force from and after its
35 publication in the statute book.

[DELETED: Aafoaofm te se bd of ps se od ape1B2N3t4b5p6p7(l es fm te ey od a8ae at gt fd sl be me in ae w9a0i1a2(3o4a5e6s7a8a9r0e1(2o3f4S5f6(]
[DELETED: 9pco(ea( (pe0t1r2(3a4(5l6a7(8a9(0t1(2l3ry d, c, ma or d, rg fm t4c5o6r7w8r9(0o1(2of ng ad ed by a sl dt to pm n3p4(5m6a7t8(9a0t1s2ae rg ad en of te pn to wm t3e]
[DELETED: 9Oott my or as a rt of ag an ey oa; t t e cd(pp0b1(2t3a4o5(6r7as 8p9a0(1(2e3(4s5i6p7(8e9(0o1a2o3a4(5d6(7(g ae dg ny ps a8p9a0(1(2s3(]
[DELETED: 9wh re c, ps or ds an ey oasae an by a pl le ey ag fm tho(oa0a1o2o3n4e5(6t7o8s9c0a1(2a3w4a5o6l7a8(9m0J1(2a3S4S5p]